[恶性胸膜间皮瘤的医学治疗。培美曲塞在当前治疗中的作用] - Suppr

Suppr

超能文献

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].

作者信息

Margery J

机构信息

Service des Maladies Respiratoires, Hôpital d'Instruction des Armées, Percy-Clamart.

出版信息

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

PMID:16273003

Abstract

摘要

相似文献

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

Pemetrexed therapy for malignant pleural mesothelioma.

Ann Pharmacother. 2005 Apr;39(4):678-83. doi: 10.1345/aph.1E329. Epub 2005 Mar 8.

Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.

Expert Rev Anticancer Ther. 2004 Jun;4(3):361-8. doi: 10.1586/14737140.4.3.361.

[Update of pemetrexed in thoracic oncology].

Bull Cancer. 2007;94 Spec No Actualites:S139-41.

The role of Alimta in the treatment of malignant pleural mesothelioma: an overview of preclinical and clinical trials.

Lung Cancer. 2004 Aug;45 Suppl 1:S121-4. doi: 10.1016/j.lungcan.2004.04.021.

Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?

Asia Pac J Clin Oncol. 2010 Dec;6(4):248-50. doi: 10.1111/j.1743-7563.2010.01362.x.

Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.

Lung Cancer. 2008 May;60(2):294-7. doi: 10.1016/j.lungcan.2007.08.031. Epub 2007 Oct 4.

TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.

Anticancer Res. 2010 Oct;30(10):4309-15.

Pemetrexed (Alimta) for mesothelioma.

Med Lett Drugs Ther. 2004 Apr 12;46(1180):31-2.

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].

作者信息

Margery J

机构信息

Service des Maladies Respiratoires, Hôpital d'Instruction des Armées, Percy-Clamart.

出版信息

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

PMID:16273003

Abstract

摘要

相似文献

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

Pemetrexed therapy for malignant pleural mesothelioma.

Ann Pharmacother. 2005 Apr;39(4):678-83. doi: 10.1345/aph.1E329. Epub 2005 Mar 8.

Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.

Expert Rev Anticancer Ther. 2004 Jun;4(3):361-8. doi: 10.1586/14737140.4.3.361.

[Update of pemetrexed in thoracic oncology].

Bull Cancer. 2007;94 Spec No Actualites:S139-41.

The role of Alimta in the treatment of malignant pleural mesothelioma: an overview of preclinical and clinical trials.

Lung Cancer. 2004 Aug;45 Suppl 1:S121-4. doi: 10.1016/j.lungcan.2004.04.021.

Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?

Asia Pac J Clin Oncol. 2010 Dec;6(4):248-50. doi: 10.1111/j.1743-7563.2010.01362.x.

Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.

Lung Cancer. 2008 May;60(2):294-7. doi: 10.1016/j.lungcan.2007.08.031. Epub 2007 Oct 4.

TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.

Anticancer Res. 2010 Oct;30(10):4309-15.

Pemetrexed (Alimta) for mesothelioma.

Med Lett Drugs Ther. 2004 Apr 12;46(1180):31-2.

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28.